FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022846836> ?p ?o ?g. }

• W2022846836 endingPage "519" @default.
• W2022846836 startingPage "513" @default.
• W2022846836 abstract "Previous data by our group demonstrated the antifungal efficacy of a vaccine consisting of laminarin (beta-(1,3)-glucan), conjugated with diphtheria toxoid, which generated protective anti-laminarin antibodies in mice. In this paper, we sought for the presence, isotype and subclass composition of natural anti-laminarin antibodies in an unselected population of human healthy subjects, in a comparison with antibodies directed against beta-(1,6)-glucan (pustulan) and branched beta-(1,3/1,6)-glucan (Pool 1) and mannan from Candida albicans. Almost all subjects showed detectable levels of anti-beta-glucan antibodies, with IgG largely prevailing on IgM, little, if any, IgA and no IgE. However, the titer of anti-beta-glucan antibodies was overall about 1log lower than that of anti-mannan antibodies of the corresponding isotype. In particular, the level of anti-laminarin IgG was the lowest one, its geometrical mean titer (95% confidence interval, CI) being 1838 (1245-2714) as compared to 8157 (6067-10,931) and 3940 (2911-5332) for pustulan and Pool 1 fungal glucan, respectively. Analysis of IgG subclass composition showed that IgG2 was the prevalent subclass against any antigen, and again the concentration of anti-laminarin IgG2 was the lowest one, its geometrical mean concentration being 0.13 (0.07-0.24)microg/ml as compared to anti-pustulan and anti-Pool 1 glucan and mannan IgG2 levels, which were 0.33 (0.2-0.5), 1.35 (0.9-2.0), and 36.1 (25.2-51.3)microg/ml, respectively. These data show that anti-laminarin antibodies are present at low levels in humans as compared to other anti-beta-glucan and, mostly, anti-mannan antibodies, and suggest that a protective antifungal vaccination in humans should attempt to tip the balance of antifungal antibodies in favour of the anti-laminarin ones." @default.
• W2022846836 created "2016-06-24" @default.
• W2022846836 creator A5041528346 @default.
• W2022846836 creator A5042995016 @default.
• W2022846836 creator A5051828043 @default.
• W2022846836 creator A5057121662 @default.
• W2022846836 date "2009-01-01" @default.
• W2022846836 modified "2023-10-18" @default.
• W2022846836 title "Anti-β-glucan antibodies in healthy human subjects" @default.
• W2022846836 cites W1483296739 @default.
• W2022846836 cites W156755335 @default.
• W2022846836 cites W1782117607 @default.
• W2022846836 cites W1966144750 @default.
• W2022846836 cites W1983565271 @default.
• W2022846836 cites W1990730477 @default.
• W2022846836 cites W1992274022 @default.
• W2022846836 cites W2014316305 @default.
• W2022846836 cites W2030421888 @default.
• W2022846836 cites W2059063969 @default.
• W2022846836 cites W2066807229 @default.
• W2022846836 cites W2071499523 @default.
• W2022846836 cites W2100033891 @default.
• W2022846836 cites W2111170139 @default.
• W2022846836 cites W2118113082 @default.
• W2022846836 cites W2118420662 @default.
• W2022846836 cites W2119235066 @default.
• W2022846836 cites W2131626693 @default.
• W2022846836 cites W2134941291 @default.
• W2022846836 cites W2135955264 @default.
• W2022846836 cites W2149149952 @default.
• W2022846836 cites W2153309282 @default.
• W2022846836 cites W2168271732 @default.
• W2022846836 cites W4236098269 @default.
• W2022846836 cites W4249736906 @default.
• W2022846836 doi "https://doi.org/10.1016/j.vaccine.2008.11.030" @default.
• W2022846836 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19041357" @default.
• W2022846836 hasPublicationYear "2009" @default.
• W2022846836 type Work @default.
• W2022846836 sameAs 2022846836 @default.
• W2022846836 citedByCount "50" @default.
• W2022846836 countsByYear W20228468362012 @default.
• W2022846836 countsByYear W20228468362013 @default.
• W2022846836 countsByYear W20228468362014 @default.
• W2022846836 countsByYear W20228468362015 @default.
• W2022846836 countsByYear W20228468362016 @default.
• W2022846836 countsByYear W20228468362017 @default.
• W2022846836 countsByYear W20228468362018 @default.
• W2022846836 countsByYear W20228468362019 @default.
• W2022846836 countsByYear W20228468362020 @default.
• W2022846836 countsByYear W20228468362021 @default.
• W2022846836 countsByYear W20228468362022 @default.
• W2022846836 countsByYear W20228468362023 @default.
• W2022846836 crossrefType "journal-article" @default.
• W2022846836 hasAuthorship W2022846836A5041528346 @default.
• W2022846836 hasAuthorship W2022846836A5042995016 @default.
• W2022846836 hasAuthorship W2022846836A5051828043 @default.
• W2022846836 hasAuthorship W2022846836A5057121662 @default.
• W2022846836 hasConcept C100817775 @default.
• W2022846836 hasConcept C159654299 @default.
• W2022846836 hasConcept C203014093 @default.
• W2022846836 hasConcept C22889606 @default.
• W2022846836 hasConcept C2776123893 @default.
• W2022846836 hasConcept C2776194381 @default.
• W2022846836 hasConcept C2777351567 @default.
• W2022846836 hasConcept C2777991845 @default.
• W2022846836 hasConcept C2778938456 @default.
• W2022846836 hasConcept C2779719659 @default.
• W2022846836 hasConcept C2780801004 @default.
• W2022846836 hasConcept C2780917455 @default.
• W2022846836 hasConcept C32611913 @default.
• W2022846836 hasConcept C542903549 @default.
• W2022846836 hasConcept C55493867 @default.
• W2022846836 hasConcept C86803240 @default.
• W2022846836 hasConcept C89423630 @default.
• W2022846836 hasConceptScore W2022846836C100817775 @default.
• W2022846836 hasConceptScore W2022846836C159654299 @default.
• W2022846836 hasConceptScore W2022846836C203014093 @default.
• W2022846836 hasConceptScore W2022846836C22889606 @default.
• W2022846836 hasConceptScore W2022846836C2776123893 @default.
• W2022846836 hasConceptScore W2022846836C2776194381 @default.
• W2022846836 hasConceptScore W2022846836C2777351567 @default.
• W2022846836 hasConceptScore W2022846836C2777991845 @default.
• W2022846836 hasConceptScore W2022846836C2778938456 @default.
• W2022846836 hasConceptScore W2022846836C2779719659 @default.
• W2022846836 hasConceptScore W2022846836C2780801004 @default.
• W2022846836 hasConceptScore W2022846836C2780917455 @default.
• W2022846836 hasConceptScore W2022846836C32611913 @default.
• W2022846836 hasConceptScore W2022846836C542903549 @default.
• W2022846836 hasConceptScore W2022846836C55493867 @default.
• W2022846836 hasConceptScore W2022846836C86803240 @default.
• W2022846836 hasConceptScore W2022846836C89423630 @default.
• W2022846836 hasIssue "4" @default.
• W2022846836 hasLocation W20228468361 @default.
• W2022846836 hasLocation W20228468362 @default.
• W2022846836 hasOpenAccess W2022846836 @default.
• W2022846836 hasPrimaryLocation W20228468361 @default.
• W2022846836 hasRelatedWork W1628283138 @default.
• W2022846836 hasRelatedWork W168309117 @default.

• next